Using a jail-based survey to monitor HIV and risk behaviors among seattle area injection drug users

Routine monitoring of human immunodeficiency virus (HIV) and risk behaviors among injection drug users (IDUs) is difficult outside drug treatment settings. We developed and implemented a survey of recently arrested IDUs to describe the prevalence of HIV, drug use, and sexual behaviors among them. A probability sampling survey was instituted in the King County Correctional Facility in Seattle, Washington, to sample recently arrested IDUs at the time of booking and in the jail health clinic between 1998 and 1999. Following HIV risk assessment and blood draw, additional information on drug use practices was gathered using a standardized questionnaire. Potential participants who were released from jail early could complete the study at a nearby research storefront office. Of the 4,344 persons intercepted at booking, 503 (12%) reported injection drug use, and 201 of the IDUs (40%) participated in the study. An additional 161 IDUs were enrolled in the study from the jail health clinic. Among the 348 unduplicated subjects, HIV prevalence was 2%; in the past 6 months, 69% reported two or more shooting partners, 72% used a cooker after someone else, 60% shared a syringe to divide up drugs, and 62% injected with used needles. Only 37% reported being hepatitis C seropositive, and 8% reported hepatitis B vaccination. It was feasible to conduct a jail-based survey of recently arrested IDUs that yielded useful information. The high prevalence of reported risky drug use practices warrants ongoing monitoring and illustrates the need for improving prevention programs for HIV and hepatitis B and C in this population, including expansion of hepatitis C screening and provision of hepatitis B vaccination at the jail health clinic.

[1]  D. D. Des Jarlais,et al.  HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. , 2000, American journal of public health.

[2]  P. Fleming,et al.  Epidemiology of AIDS in incarcerated persons in the United States, 1994-1996. , 1999, AIDS.

[3]  M Beardsley,et al.  Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. , 1998, American journal of public health.

[4]  N. Weiss,et al.  Syringe exchange and risk of infection with hepatitis B and C viruses. , 1999, American journal of epidemiology.

[5]  M. Anglin,et al.  Long-term trends in self-reported HIV risk behavior: injection drug users in Los Angeles, 1987 through 1995. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[6]  M. Kennedy,et al.  HIV prevention in prisons and jails: obstacles and opportunities. , 1994, Public health reports.

[7]  N. Mahon New York inmates' HIV risk behaviors: the implications for prevention policy and programs. , 1996, American journal of public health.

[8]  D. Vlahov,et al.  Prevalence of antibody to HIV-1 among entrants to US correctional facilities. , 1991, JAMA.

[9]  D. Vlahov,et al.  Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. , 1989, Journal of acquired immune deficiency syndromes.

[10]  J. Moatti,et al.  HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons , 1994, AIDS.

[11]  T. Hammett,et al.  Reaching Seriously At-Risk Populations: Health Interventions in Criminal Justice Settings , 1998, Health education & behavior : the official publication of the Society for Public Health Education.

[12]  A. Edwards,et al.  Survey of risk behaviour and HIV prevalence in an English prison , 1999, International journal of STD & AIDS.

[13]  M. Gwinn,et al.  Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993. , 1996, American journal of epidemiology.

[14]  I. Onorato,et al.  The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. , 1990, Public health reports.

[15]  M. Bourlière,et al.  HBV and HIV screening, and hepatitis B immunization programme in the prison of Marseille, France , 1997, International journal of STD & AIDS.

[16]  S. Gore,et al.  Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie , 1995, AIDS.

[17]  R. Reindollar Hepatitis C and the correctional population. , 1999, The American journal of medicine.

[18]  T. S. Jones,et al.  HIV seroprevalence surveys in drug treatment centers. , 1990, Public health reports.

[19]  W. H. Hall,et al.  Effective medical treatment of opiate addiction , 1998 .

[20]  M. Pappaioanou,et al.  Monitoring the levels and trends of HIV infection: the Public Health Service's HIV surveillance program. , 1988, Public health reports.

[21]  L. Metsch,et al.  Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[22]  Julio S. G. Montaner,et al.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.

[23]  M. Anglin,et al.  Trends in self-reported HIV risk behavior: injection drug users in Los Angeles. , 1993, Journal of acquired immune deficiency syndromes.

[24]  R. Booth,et al.  The prevalence of additional injection-related HIV risk behaviors among injection drug users. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[25]  C. Stefanis,et al.  A survey of bloodborne viruses and associated risk behaviours in Greek prisons. , 1998, Addiction.

[26]  C. Carpenter,et al.  Prevalence of HIV-1 among recent arrestees in Los Angeles County, California: serial cross-sectional study, 1991-1995. , 1999, Journal of acquired immune deficiency syndromes.